National Research (NASDAQ:NRC) Sets New 52-Week High – Here’s What Happened

National Research Corporation (NASDAQ:NRC) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $23.00 and last traded at $22.2450, with a volume of 5181 shares changing hands. The stock had previously closed at $22.40.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on NRC shares. Citizens Jmp began coverage on shares of National Research in a research report on Monday, June 22nd. They set a “market outperform” rating and a $23.00 target price on the stock. Weiss Ratings raised shares of National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $23.00.

National Research Trading Down 4.0%

The company has a market cap of $497.54 million, a price-to-earnings ratio of 56.08 and a beta of 0.35. The firm has a 50 day moving average price of $19.51 and a two-hundred day moving average price of $18.05. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 5.48.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Tuesday, April 28th. The company reported $0.21 EPS for the quarter. The company had revenue of $34.80 million for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 10th. Shareholders of record on Friday, June 26th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, June 26th. This represents a $0.64 annualized dividend and a yield of 2.9%. National Research’s dividend payout ratio (DPR) is presently 164.10%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of NRC. Empowered Funds LLC acquired a new stake in National Research during the 1st quarter worth about $226,000. Bank of America Corp DE increased its stake in National Research by 3.0% during the 1st quarter. Bank of America Corp DE now owns 112,468 shares of the company’s stock valued at $1,910,000 after purchasing an additional 3,323 shares in the last quarter. Quantinno Capital Management LP increased its position in shares of National Research by 61.3% during the first quarter. Quantinno Capital Management LP now owns 62,329 shares of the company’s stock worth $1,058,000 after acquiring an additional 23,682 shares in the last quarter. Heartland Advisors Inc. increased its holdings in National Research by 374.3% during the 1st quarter. Heartland Advisors Inc. now owns 237,147 shares of the company’s stock worth $4,027,000 after purchasing an additional 187,147 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in National Research by 4.0% in the 1st quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock valued at $4,257,000 after buying an additional 9,730 shares during the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.